John R. Wilson - 15 Aug 2025 SCHEDULE 13D/A Report for Marker Therapeutics, Inc. Common Stock, Par Value $0.001 (MRKR)

Filing Manager: John R. Wilson
Reporting Manager: John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017
Security: Marker Therapeutics, Inc. Common Stock, Par Value $0.001
Symbol: MRKR
Shares outstanding: 12,939,235 shares
Disclosed Ownership: 659,901 shares
Ownership: 5.1%
Form type: SCHEDULE 13D/A
Filing time: 19 Aug 2025, 14:42:51 UTC
Date of event: 15 Aug 2025
Next filing: 20 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017	5.1%	659,901	659,901	0	/s/ John R. Wilson	John R. Wilson/Trustee	0001755569